ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
ADARx Pharmaceuticals, Inc.
$17.63−0.02 (-0.11%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Statistics
Not enough reported data
Statistics need ADARx Pharmaceuticals's reported income statement and balance sheet.